Cyril Barinka investigador
Bařinka, Cyril
VIAF ID: 145914232 (Personal)
Permalink: http://viaf.org/viaf/145914232
Preferred Forms
-
- 100 0 _ ‡a Cyril Barinka ‡c investigador
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
2-Aminoadipic Acid-C(O)-Glutamate Based Prostate-Specific Membrane Antigen Ligands for Potential Use as Theranostics | |
Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure–activity relationship studies | |
Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome | |
Calcium-Driven Folding of RTX Domain β-Rolls Ratchets Translocation of RTX Proteins through Type I Secretion Ducts | |
Cellular Delivery of Bioorthogonal Pretargeting Therapeutics in PSMA-Positive Prostate Cancer | |
Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities | |
Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy | |
Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity | |
Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models | |
Discovery of a para-Acetoxy-benzyl Ester Prodrug of a Hydroxamate-Based Glutamate Carboxypeptidase II Inhibitor as Oral Therapy for Neuropathic Pain. | |
The disordered N-terminus of HDAC6 is a microtubule-binding domain critical for efficient tubulin deacetylation | |
Engineered Fragments of the PSMA-Specific 5D3 Antibody and Their Functional Characterization | |
Evaluation of 111In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen | |
Glu-Ureido-Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers | |
Histone Deacetylase 11 Is a Fatty-Acid Deacylase. | |
Homology modeling and SAR analysis of Schistosoma japonicum cathepsin D (SjCD) with statin inhibitors identify a unique active site steric barrier with potential for the design of specific inhibitors. | |
Human histone deacetylase 6 shows strong preference for tubulin dimers over assembled microtubules | |
Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity | |
In‐solution structure and oligomerization of human histone deacetylase 6 – an integrative approach | |
Mitochondria-adaptor TRAK1 promotes kinesin-1 driven transport in crowded environments | |
Mouse brain serine racemase catalyzes specific elimination of L-serine to pyruvate | |
Novel Monoclonal Antibodies Recognizing Human Prostate-Specific Membrane Antigen (PSMA) as Research and Theranostic Tools. | |
One-Atom Substitution Enables Direct and Continuous Monitoring of Histone Deacylase Activity | |
A picomolar inhibitor of resistant strains of human immunodeficiency virus protease identified by a combinatorial approach. | |
Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide. | |
Reaction mechanism of glutamate carboxypeptidase II revealed by mutagenesis, X-ray crystallography, and computational methods | |
A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules | |
Resonance Assignment and Three-Dimensional Structure Determination of a Human α-Defensin, HNP-1, by Solid-State NMR | |
Structural basis of interaction between urokinase-type plasminogen activator and its receptor | |
Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II | |
Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer | |
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer | |
Structure of human monocyte chemoattractant protein 4 (MCP-4/CCL13) | |
Synthesis and Pharmacological Evaluation of Selective Histone Deacetylase 6 Inhibitors in Melanoma Models. | |
Tissue expression and enzymologic characterization of human prostate specific membrane antigen and its rat and pig orthologs | |
Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological Activity | |
The unraveling of substrate specificity of histone deacetylase 6 domains using acetylome peptide microarrays and peptide libraries |